Page 45 - நுரையீரல் உயர் இரத்த அழுத்தம் ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நுரையீரல் உயர் இரத்த அழுத்தம் ப்ரோக்ர்யாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நுரையீரல் உயர் இரத்த அழுத்தம் ப்ரோக்ர்யாம் Today - Breaking & Trending Today

Tauranga boy pleads for Trikafta drug to ease cystic fibrosis


Tauranga boy pleads for Trikafta drug to ease cystic fibrosis
19 Feb, 2021 10:00 PM
7 minutes to read
Harry Oxenham has cystic fibrosis and hopes a treatment drug will change his life. Photo / George Novak
Harry Oxenham has cystic fibrosis and hopes a treatment drug will change his life. Photo / George Novak
It s a little like the sound of a dishwasher or the
washing machine.
The sound is relentless - constantly filling the silence
of thought as Harry s parents, Aly, Dan and I talk.
Ironically, relentless is how Aly describes the half-hour treatment regime that sees Harry using three different mouthpieces, to achieve three different results for the sticky mucus on his lungs, otherwise known as cystic fibrosis. ....

New Zealand , New Zealanders , Jane Bollard , Harry Oxenham , Rotorua Leah Rumney , Lisa Williams , Leah Rumney , Rotorua Daily Post Weekend , Fibrosis New Zealand , Cystic Fibrosis New Zealand , Trikafta For Kiwis , Harry S , புதியது ஜீலாந்து , ஜேன் பொல்லார்ட் , லிசா வில்லியம்ஸ் , லியா ரம்னி , ஃபைப்ரோஸிஸ் புதியது ஜீலாந்து , சிஸ்டிக் ஃபைப்ரோஸிஸ் புதியது ஜீலாந்து , ஹாரி கள் ,

Study: Asthma does not increase risk of severe illness or death from COVID-19


Study: Asthma does not increase risk of severe illness or death from COVID-19
A new study looking at how COVID-19 affects people with asthma provides reassurance that having the condition doesn t increase the risk of severe illness or death from the virus.
George Institute for Global Health researchers in Australia analyzed data from 57 studies with an overall sample size of 587,280. Almost 350,000 people in the pool had been infected with COVID-19 from Asia, Europe, and North and South America and found they had similar proportions of asthma to the general population.
The results, published in the peer-reviewed
Journal of Asthma, show that just over seven in every 100 people who tested positive for COVID-19 also had asthma, compared to just over eight in 100 in the general population having the condition. They also showed that people with asthma had a 14 percent lower risk of acquiring COVID-19 and were significantly less likely to be hospitalized with the virus. ....

United States , Anthony Sunjaya , Christine Jenkins , Emily Henderson , Institute Respiratory Program , George Institute For Global Health , Global Health , South America , Respiratory Program , Professor Christine Jenkins , Middle East Respiratory Syndrome , Asthma Australia , North America , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸ்டின் ஜென்கின்ஸ் , எமிலி ஹென்டர்சன் , நிறுவனம் சுவாச ப்ரோக்ர்யாம் , ஜார்ஜ் நிறுவனம் க்கு உலகளாவிய ஆரோக்கியம் , உலகளாவிய ஆரோக்கியம் , தெற்கு அமெரிக்கா , சுவாச ப்ரோக்ர்யாம் , ப்ரொஃபெஸர் கிறிஸ்டின் ஜென்கின்ஸ் , நடுத்தர கிழக்கு சுவாச நோய்க்குறி , ஆஸ்துமா ஆஸ்திரேலியா , வடக்கு அமெரிக்கா ,

COVID-19 and lung cancer have a common pathway, say researchers


COVID-19 and lung cancer have a common pathway, say researchers
The coronavirus disease 2019 (COVID-19) is a transmissible viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the ongoing global pandemic. The virus was first detected in Wuhan, China, at the end of 2019 and to date has caused over 109 million infections worldwide.
With over 2.4 million deaths, this virus can cause severe disease in certain high-risk groups such as those with metabolic syndrome, diabetes, cardiovascular disease and an abnormally high body mass index (BMI). A new preprint on the
bioRxiv server describes the common features shared by this condition with lung cancer. ....

Liji Thomas , Coronavirus Disease Covid 19 , Lung Cancer , Sars Cov 2 , Body Mass Index , Cardiovascular Disease , Cell Migration , Cell Proliferation , Chronic Obstructive Pulmonary Disease , Corona Virus , Growth Factor , Immune Response , Metabolic Syndrome , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , Viral Disease , நுரையீரல் புற்றுநோய் , உடல் நிறை குறியீட்டு , இருதய நோய் , செல் இடம்பெயர்வு , நாள்பட்ட தடைசெய்யும் நுரையீரல் நோய் , கொரோனா வைரஸ் , நீரிழிவு நோய் , வளர்ச்சி காரணி , நோய் எதிர்ப்பு சக்தி பதில் , வளர்சிதை மாற்ற நோய்க்குறி ,

Could measles virus vectors be used for a new COVID-19 vaccine?


Could measles virus vectors be used for a new COVID-19 vaccine?
Vaccines may come in several forms, one of the most common being live-attenuated. Live-attenuated vaccines are a weakened form of the virus, created by genetic modification, and usually provide long-lasting immunity. Many research groups and companies have been working tirelessly since the outbreak of COVID-19 to develop vaccines by a number of routes, though no live-attenuated vaccine has thus far been approved.
A paper recently released on the pre-print server
bioRxiv by a research team at the Institut Pasteur in France describes the successful development of such a vaccine utilizing a measles virus vector. ....

Institut Pasteur , Michael Greenwood , Image Credit , Coronavirus Disease Covid 19 , Sars Cov 2 , Immune Response , Spike Protein , நிறுவனம் பாஸ்டர் , மைக்கேல் கிரீன்வுட் , படம் கடன் , நோய் எதிர்ப்பு சக்தி பதில் , நானோ துகள்கள் , ஸ்பைக் ப்ரோடீந் ,